Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
PLoS One
    January 2025
  1. EUESDEN J, Ali M, Robins C, Surendran P, et al
    Patient stratification by genetic risk in Alzheimer's disease is only effective in the presence of phenotypic heterogeneity.
    PLoS One. 2025;20:e0310977.
    >> Share

  2. LATHIKA RAJENDRAKUMAR A, Arbeev KG, Bagley O, Duan M, et al
    APOE4 and infectious diseases jointly contribute to brain glucose hypometabolism, a biomarker of Alzheimer's pathology: New findings from the ADNI.
    PLoS One. 2025;20:e0316808.
    >> Share

  3. RAO GA, Shoaibi A, Makadia R, Hardin J, et al
    CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization.
    PLoS One. 2025;20:e0310634.
    >> Share

  4. GUERGUER FZ, Bouribab A, Karim EM, Khedraoui M, et al
    Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
    PLoS One. 2025;20:e0313411.
    >> Share

  5. NERATTINI M, Williams S, Andy C, Carlton C, et al
    Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.
    PLoS One. 2025;20:e0317303.
    >> Share

  6. WU Y, Cleverley K, Wiseman FK
    Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy 21 human cellular and mouse models.
    PLoS One. 2025;20:e0316822.
    >> Share

  7. GUERGUER FZ, Rossafi B, Abchir O, Raouf YS, et al
    Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors.
    PLoS One. 2025;20:e0317261.
    >> Share

  8. LU H, Ni X, Man Chan SS, Cheng CPW, et al
    Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial.
    PLoS One. 2025;20:e0317700.
    >> Share

  9. LI X, Gong B, Chen X, Li H, et al
    Alzheimer's disease image classification based on enhanced residual attention network.
    PLoS One. 2025;20:e0317376.
    >> Share

  10. VITALI F, Wiegand JP, Parker-Halstead L, Tucker A, et al
    Weight trajectories in aging humanized APOE mice with translational validity to human Alzheimer's risk population: A retrospective analysis.
    PLoS One. 2025;20:e0314097.
    >> Share

  11. LIU N, Deng Q, Peng Z, Mao D, et al
    Characterization of gene expression profiles in Alzheimer's disease and osteoarthritis: A bioinformatics study.
    PLoS One. 2025;20:e0316708.
    >> Share

  12. WAN Z, Ma T
    The impact of apolipoprotein E, type ?4 allele on Alzheimer's disease pathological biomarkers: a comprehensive post-mortem pilot-analysis.
    PLoS One. 2025;20:e0303486.
    >> Share

  13. YAN H, Mubonanyikuzo V, Komolafe TE, Zhou L, et al
    Hybrid-RViT: Hybridizing ResNet-50 and Vision Transformer for Enhanced Alzheimer's disease detection.
    PLoS One. 2025;20:e0318998.
    >> Share

  14. NEAL SJ, Chitta S, Magden ER, Simmons JH, et al
    Characterizing plasma and cerebrospinal fluid biomarkers relevant to neurodegeneration in captive olive baboons (Papio anubis).
    PLoS One. 2025;20:e0318173.
    >> Share

  15. LI J, Tao L, Zhou Y, Zhu Y, et al
    Identification of biomarkers in Alzheimer's disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms.
    PLoS One. 2025;20:e0317915.
    >> Share


  16. Expression of Concern: Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce beta-amyloid in Alzheimer's disease.
    PLoS One. 2025;20:e0319769.
    >> Share

  17. MCCOOL S, Smith JC, Sladek A, Fan S, et al
    Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease.
    PLoS One. 2025;20:e0319397.
    >> Share

  18. SU C, Zhang S, Zheng Q, Miao J, et al
    Prevalence and correlation of sarcopenia with Alzheimer's disease: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0318920.
    >> Share

  19. TAKOMTHONG P, Waiwut P, Yenjai C, Wangboonskul J, et al
    Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice.
    PLoS One. 2025;20:e0316888.
    >> Share

  20. WANG Z, Li Z, Lin A, Zhang Q, et al
    Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches.
    PLoS One. 2025;20:e0317716.
    >> Share


  21. Retraction: Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    PLoS One. 2025;20:e0321152.
    >> Share

  22. HONDA K, Awazu A
    Potential multiple disease progression pathways in female patients with Alzheimer's disease inferred from transcriptome and epigenome data of the dorsolateral prefrontal cortex.
    PLoS One. 2025;20:e0313733.
    >> Share

  23. SILLAPAKONG P, Wakabayashi T, Suzuki K
    Naturido alleviates amyloid beta1-42-induced adverse effects in a transgenic Caenorhabditis elegans model of Alzheimer's disease.
    PLoS One. 2025;20:e0320636.
    >> Share

  24. MORISAKI M, Rezaali F, Lau LC, Boche D, et al
    Depression as a risk factor for Alzheimer's disease: A human post-mortem study.
    PLoS One. 2025;20:e0320561.
    >> Share

  25. ZSQA-UR-REHMAN, Awang MK, Rashid J, Ali G, et al
    Correction: Classification of Alzheimer disease using DenseNet-201 based on deep transfer learning technique.
    PLoS One. 2025;20:e0321795.
    >> Share

  26. MENG M, Shen X, Xie Y, Lan R, et al
    Insomnia and risk of all-cause dementia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0318814.
    >> Share

  27. ALRUILY M, Abd El-Aziz AA, Mostafa AM, Ezz M, et al
    Ensemble deep learning for Alzheimer's disease diagnosis using MRI: Integrating features from VGG16, MobileNet, and InceptionResNetV2 models.
    PLoS One. 2025;20:e0318620.
    >> Share

  28. AMIN H, Bukhari SA, Chauhdary Z, Akhter N, et al
    Vigna radiata extracts in pumpkin and soya bean oil: A novel therapeutic approach for Alzheimer's disease.
    PLoS One. 2025;20:e0321183.
    >> Share

  29. JEMIMAH S, Abuhantash F, AlShehhi A
    c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer's disease.
    PLoS One. 2025;20:e0320360.
    >> Share

  30. LICHTY JD, Mane H, Yarmey VR, Miguel AS, et al
    Amyloid beta induces hormetic-like effects through major stress pathways in a C. elegans model of Alzheimer's Disease.
    PLoS One. 2025;20:e0315810.
    >> Share

  31. KAMIYA M, Osawa A, Otaka E, Kato K, et al
    Exploring emotion recognition in patients with mild cognitive impairment and Alzheimer's dementia undergoing a rehabilitation program emotion recognition in patients with dementia.
    PLoS One. 2025;20:e0322213.
    >> Share

  32. JOHNSON KJ, Johnson K, Grant A, Taglialatela G, et al
    Photobiomodulation therapy increases neural stem cell pool in aged 3xTg-AD mice.
    PLoS One. 2025;20:e0321668.
    >> Share

  33. TAO F, Deng S, Zhuo B, Liu J, et al
    Causal relationship between schizophrenia and five types of dementia: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2025;20:e0322752.
    >> Share


  34. Retraction: Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer's disease treatment.
    PLoS One. 2025;20:e0324094.
    >> Share

  35. LIU S, Geng D
    A systematic analysis for disease burden, risk factors, and trend projection of Alzheimer's disease and other dementias in China and globally.
    PLoS One. 2025;20:e0322574.
    >> Share

  36. CATTO F, Kirschenbaum D, Economides AE, Reuss AM, et al
    Quantitative 3D histochemistry reveals region-specific amyloid-beta reduction by the antidiabetic drug netoglitazone.
    PLoS One. 2025;20:e0309489.
    >> Share

  37. BRUNO F, Aceto MA, Paparazzo E, Arcuri D, et al
    Genetic variability in ADAM17/TACE is associated with sporadic Alzheimer's disease risk, neuropsychiatric symptoms and cognitive performance on the Rey Auditory Verbal Learning and Clock Drawing Tests.
    PLoS One. 2025;20:e0309631.
    >> Share

  38. SADEGHI A, Noorbakhshnia M, Khodashenas S
    Protective potential of BM-MSC extracted Exosomes in a rat model of Alzheimer's disease.
    PLoS One. 2025;20:e0320883.
    >> Share

  39. KAYHAN KOCAK FO, Kumral E
    The relationship between dementia staging scales, cognitive-behavioral scales and functionality in patients with cognitive impairment.
    PLoS One. 2025;20:e0322572.
    >> Share

    January 2024
  40. PARKS ME
    Stochastic model of Alzheimer's disease progression using two-state Markov chains.
    PLoS One. 2024;19:e0295578.
    >> Share

  41. KONG F, Wu T, Dai J, Cai J, et al
    Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022.
    PLoS One. 2024;19:e0295008.
    >> Share

  42. GAMMIE SC, Messing A, Hill MA, Kelm-Nelson CA, et al
    Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease.
    PLoS One. 2024;19:e0291995.
    >> Share


  43. Editorial Note: Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease.
    PLoS One. 2024;19:e0297928.
    >> Share

  44. NEUDORF B, Dinh C, Barnes V, Stergiou-Dayment C, et al
    Enhancing Minds in Motion(R) as a virtual program delivery model for people living with dementia and their care partners.
    PLoS One. 2024;19:e0291166.
    >> Share

  45. PAPAZOGLOU A, Henseler C, Weickhardt S, Teipelke J, et al
    Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice.
    PLoS One. 2024;19:e0296959.
    >> Share

  46. BELLIO TA, Laguna-Torres JY, Campion MS, Chou J, et al
    Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Abeta42 deposition in AppNL-G-F Alzheimer's disease model mice.
    PLoS One. 2024;19:e0297289.
    >> Share

  47. SINGH S, Cocoros NM, Li X, Mazor KM, et al
    Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controll
    PLoS One. 2024;19:e0297562.
    >> Share

  48. KO YK, Kim E, Lee EJ, Nam SJ, et al
    Enrichment of infection-associated bacteria in the low biomass brain bacteriota of Alzheimer's disease patients.
    PLoS One. 2024;19:e0296307.
    >> Share

  49. LI YS, Xia YG, Liu YL, Jiang WR, et al
    Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297883.
    >> Share

  50. SHAHID SS, Dzemidzic M, Butch ER, Jarvis EE, et al
    Estimating the synaptic density deficit in Alzheimer's disease using multi-contrast CEST imaging.
    PLoS One. 2024;19:e0299961.
    >> Share

  51. ABAYOMI SN, Sritharan P, Yan E, Saripella A, et al
    The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment-A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298686.
    >> Share

  52. AHMADI M, Javaheri D, Khajavi M, Danesh K, et al
    A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction.
    PLoS One. 2024;19:e0297996.
    >> Share

  53. ROYALL DR, Palmer RF
    INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach.
    PLoS One. 2024;19:e0295386.
    >> Share

  54. YU F, Pituch KA, Maxfield M, Baena E, et al
    The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
    PLoS One. 2024;19:e0295749.
    >> Share

  55. PEREIRA AAR, Pinto AM, Malerba HN, Toricelli M, et al
    Microdose lithium improves behavioral deficits and modulates molecular mechanisms of memory formation in female SAMP-8, a mouse model of accelerated aging.
    PLoS One. 2024;19:e0299534.
    >> Share

  56. AWARAYI NS, Twum F, Hayfron-Acquah JB, Owusu-Agyemang K, et al
    A bilateral filtering-based image enhancement for Alzheimer disease classification using CNN.
    PLoS One. 2024;19:e0302358.
    >> Share

  57. LEE C, Friedman A
    Generating PET scan patterns in Alzheimer's by a mathematical model.
    PLoS One. 2024;19:e0299637.
    >> Share

  58. LACEY C, Paterson T, Gawryluk JR
    Impact of APOE-epsilon alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
    PLoS One. 2024;19:e0292576.
    >> Share

  59. FUKUDA M, Okanishi H, Ino D, Ono K, et al
    Disturbance in the protein landscape of cochlear perilymph in an Alzheimer's disease mouse model.
    PLoS One. 2024;19:e0303375.
    >> Share

  60. NABAR NR, Yuan F, Lin X, Wang L, et al
    Correction: Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice.
    PLoS One. 2024;19:e0303619.
    >> Share

  61. OTA A, Kitamura H, Sugimoto K, Ogawa M, et al
    Comparative studies of hair shaft components between healthy and diseased donors.
    PLoS One. 2024;19:e0301092.
    >> Share

  62. WOOLF B, Gill D, Grant AJ, Burgess S, et al
    MVMRmode: Introducing an R package for plurality valid estimators for multivariable Mendelian randomisation.
    PLoS One. 2024;19:e0291183.
    >> Share

  63. TAMADA Y, Kusama T, Ono S, Maeda M, et al
    Validity of claims-based definition of number of remaining teeth in Japan: Results from the Longevity Improvement and Fair Evidence Study.
    PLoS One. 2024;19:e0299849.
    >> Share

  64. ABUAWAD M, Rjoub A, Dumaidi Y, Daraghma M, et al
    Evaluation of knowledge and attitudes regarding Alzheimer's disease and related dementia among medical students in Palestine: A cross-sectional study.
    PLoS One. 2024;19:e0304012.
    >> Share

  65. BURKE JF, Copeland LL, Sussman JB, Hayward RA, et al
    Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM).
    PLoS One. 2024;19:e0300005.
    >> Share

  66. NADKARNI R, Han ZY, Anderson RJ, Allphin AJ, et al
    High-resolution hybrid micro-CT imaging pipeline for mouse brain region segmentation and volumetric morphometry.
    PLoS One. 2024;19:e0303288.
    >> Share

  67. SONG B, Yoshida S
    Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
    PLoS One. 2024;19:e0303278.
    >> Share

  68. RHODIUS-MEESTER HFM, van Maurik IS, Collij LE, van Gils AM, et al
    Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.
    PLoS One. 2024;19:e0303111.
    >> Share

  69. HASSANZADEH R, Abrol A, Pearlson G, Turner JA, et al
    A confounder controlled machine learning approach: Group analysis and classification of schizophrenia and Alzheimer's disease using resting-state functional network connectivity.
    PLoS One. 2024;19:e0293053.
    >> Share

  70. AZIZAN Z, Zali H, Mirmotalebisohi SA, Bazrgar M, et al
    Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug repurposing.
    PLoS One. 2024;19:e0304410.
    >> Share

  71. FELDMAN HH, Luchsinger JA, Leger GC, Taylor C, et al
    Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).
    PLoS One. 2024;19:e0302998.
    >> Share

  72. LOPES DA CUNHA P, Ruiz F, Ferrante F, Sterpin LF, et al
    Automated free speech analysis reveals distinct markers of Alzheimer's and frontotemporal dementia.
    PLoS One. 2024;19:e0304272.
    >> Share

  73. DENKINGER M, Baker S, Inglis B, Kobayashi S, et al
    Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults.
    PLoS One. 2024;19:e0299764.
    >> Share

  74. AZMAL M, Hossen MS, Shohan MNH, Taqui R, et al
    A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
    PLoS One. 2024;19:e0304490.
    >> Share

  75. LIAO K, Lou Q
    Alzheimer's disease increases the risk of erectile dysfunction independent of cardiovascular diseases: A mendelian randomization study.
    PLoS One. 2024;19:e0303338.
    >> Share

  76. SANO M, Nishiura Y, Morikawa I, Hoshino A, et al
    Analysis of the alpha activity envelope in electroencephalography in relation to the ratio of excitatory to inhibitory neural activity.
    PLoS One. 2024;19:e0305082.
    >> Share

  77. MOHAMMADI A, Mohammadi M, Almasi-Dooghaee M, Mirmosayyeb O, et al
    Neutrophil to lymphocyte ratio in Alzheimer's disease: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0305322.
    >> Share

  78. HAQUE MA, Park IS
    An expeditious and facile method of amyloid beta (1-42) purification.
    PLoS One. 2024;19:e0307213.
    >> Share


  79. Retraction: Silencing GADD153/CHOP Gene Expression Protects against Alzheimer's Disease-Like Pathology Induced by 27-Hydroxycholesterol in Rabbit Hippocampus.
    PLoS One. 2024;19:e0307751.
    >> Share

  80. KELEMEN L, Gupta I, Yavarow Z, Smith SI, et al
    Clinician's perspectives on gene therapy for Alzheimer's disease: A qualitative study.
    PLoS One. 2024;19:e0307567.
    >> Share

  81. LUO S, Guo L, Chen N, Guo Q, et al
    CRY2 mediates the cognitive decline induced by sleep deprivation in 5xFAD mice.
    PLoS One. 2024;19:e0306930.
    >> Share

  82. AHMAD SR, Zeyaullah M, AlShahrani AM, Khan MS, et al
    Exploring the most promising anti - Depressant drug targeting Microtubule Affinity Receptor Kinase 4 involved in Alzheimer's Disease through molecular docking and molecular dynamics simulation.
    PLoS One. 2024;19:e0301179.
    >> Share

  83. RAJABLI F, Emekci A
    Addressing overlapping sample challenges in genome-wide association studies: Meta-reductive approach.
    PLoS One. 2024;19:e0296207.
    >> Share

  84. OSTERGAARD FG, Penninx BWJH, Das N, Arango C, et al
    The aperiodic exponent of neural activity varies with vigilance state in mice and men.
    PLoS One. 2024;19:e0301406.
    >> Share

  85. MEGHDADI AH, Salat D, Hamilton J, Hong Y, et al
    EEG and ERP biosignatures of mild cognitive impairment for longitudinal monitoring of early cognitive decline in Alzheimer's disease.
    PLoS One. 2024;19:e0308137.
    >> Share

  86. XIA C, Zhou M, Dong X, Zhao Y, et al
    Ginkgo biloba extract inhibits hippocampal neuronal injury caused by mitochondrial oxidative stress in a rat model of Alzheimer's disease.
    PLoS One. 2024;19:e0307735.
    >> Share

  87. WANG Y, Li M, Haughton D, Kazis LE, et al
    Transition of mild cognitive impairment to Alzheimer's disease: Medications as modifiable risk factors.
    PLoS One. 2024;19:e0306270.
    >> Share

  88. KAUFMANN L, Gruenbaum T, Janssen R, Weiss EM, et al
    Predictive value of somatic and functional variables for cognitive deterioration for early-stage patients with Alzheimer's Disease: Evidence from a prospective registry on dementia.
    PLoS One. 2024;19:e0307111.
    >> Share

  89. HORI A, Inaba H, Hato T, Tanaka K, et al
    Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer's disease.
    PLoS One. 2024;19:e0291887.
    >> Share

  90. FUNG KW, Baye F, Baik SH, McDonald CJ, et al
    Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees.
    PLoS One. 2024;19:e0309222.
    >> Share

  91. HEGEDUS E, Pakaski M, Gosztolya G, Hoffmann I, et al
    Speech-related parameters are sensitive measures of acetylcholinesterase inhibitor therapy in mild Alzheimer's disease.
    PLoS One. 2024;19:e0308409.
    >> Share

  92. MEEHAN C, Lecocq S, Penner G
    A reproducible approach for the use of aptamer libraries for the identification of Aptamarkers for brain amyloid deposition based on plasma analysis.
    PLoS One. 2024;19:e0307678.
    >> Share

  93. ZIA-UR-REHMAN, Awang MK, Rashid J, Ali G, et al
    Classification of Alzheimer disease using DenseNet-201 based on deep transfer learning technique.
    PLoS One. 2024;19:e0304995.
    >> Share

  94. PARVAND M, Liang JJH, Bozorgmehr T, Born D, et al
    A familial Alzheimer's disease associated mutation in presenilin-1 mediates amyloid-beta independent cell specific neurodegeneration.
    PLoS One. 2024;19:e0289435.
    >> Share

  95. SHIN YB, Kim JH, Kwon MK, Myung JH, et al
    Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS/MS, and design of experiments approach.
    PLoS One. 2024;19:e0309802.
    >> Share

  96. RAMIREZ J, Saleh IG, Yanagawa ESK, Shimogawa M, et al
    Multivalency drives interactions of alpha-synuclein fibrils with tau.
    PLoS One. 2024;19:e0309416.
    >> Share

  97. INAGAWA Y, Inagawa S, Takenoshita N, Yamamoto R, et al
    Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies.
    PLoS One. 2024;19:e0309885.
    >> Share

  98. STELLICK BEDREJO CA, Greenshaw A, Paulden M, Yap S, et al
    Do beta-amyloid-targeted interventions improve cognition, physical functioning, and overt behaviour of Alzheimer's Disease (AD) patients: Protocol for meta-analysis of Phase 3 clinical trials both completed and terminated.
    PLoS One. 2024;19:e0307761.
    >> Share

  99. NEELOTPOL S, Rezwan R, Singh T, Mayesha II, et al
    Pharmacological intervention of behavioural traits and brain histopathology of prenatal valproic acid-induced mouse model of autism.
    PLoS One. 2024;19:e0308632.
    >> Share

  100. YANG X, Hong K, Zhang D, Wang K, et al
    Early diagnosis of Alzheimer's Disease based on multi-attention mechanism.
    PLoS One. 2024;19:e0310966.
    >> Share

  101. KRYUKOVA OV, Korostin DO, Belova VA, Cheranev VV, et al
    Effect of ACE mutations on blood ACE phenotype parameters.
    PLoS One. 2024;19:e0308289.
    >> Share

  102. LEE M, Ahn KS, Kim M
    Effects of Artemisia asiatica ex on Akkermansia muciniphila dominance for modulation of Alzheimer's disease in mice.
    PLoS One. 2024;19:e0312670.
    >> Share

  103. ASHRAF T, Idrees N, Belay MB
    Regression analysis of topological indices for predicting efficacy of Alzheimer's drugs.
    PLoS One. 2024;19:e0309477.
    >> Share

  104. YOON G, Kam MK, Koh YH, Jo C, et al
    Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
    PLoS One. 2024;19:e0313507.
    >> Share

  105. ZHANG XY, Zhang H, Bao QN, Yin ZH, et al
    Diagnostic value of arterial spin labeling for Alzheimer's disease: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0311016.
    >> Share

  106. SHEN H, Nie J, Li G, Tian H, et al
    Stem cell factor restrains endoplasmic reticulum stress-associated apoptosis through c-Kit receptor activation of JAK2/STAT3 axis in hippocampal neuronal cells.
    PLoS One. 2024;19:e0310872.
    >> Share

  107. HE R, Zhang Q, Wang L, Hu Y, et al
    Exploring the feasibility of using mice as a substitute model for investigating microglia in aging and Alzheimer's disease though single cell analysis.
    PLoS One. 2024;19:e0311374.
    >> Share

  108. MAFI JN, Walling AM, Villaflores C, Vangala S, et al
    Correction: A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related
    PLoS One. 2024;19:e0315516.
    >> Share

  109. ZHOU X, Kedia S, Meng R, Gerstein M, et al
    Deep learning analysis of fMRI data for predicting Alzheimer's Disease: A focus on convolutional neural networks and model interpretability.
    PLoS One. 2024;19:e0312848.
    >> Share

  110. ALROUJI M, Yasmin S, Alshammari MS, Alhumaydhi FA, et al
    Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery.
    PLoS One. 2024;19:e0316010.
    >> Share

  111. MUSA MS, Islam MT, Billah W, Hossain MS, et al
    Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer's disease treatment.
    PLoS One. 2024;19:e0311401.
    >> Share

  112. SAEED A, Waris A, Fuwad A, Iqbal J, et al
    Random survival forest model for early prediction of Alzheimer's disease conversion in early and late Mild cognitive impairment stages.
    PLoS One. 2024;19:e0314725.
    >> Share

  113. YANG X, Fan Z, Li Z, Zhou J, et al
    Resting-state EEG microstate features for Alzheimer's disease classification.
    PLoS One. 2024;19:e0311958.
    >> Share

  114. SHIM SR, Kim JY, Kwon KY, Shin J, et al
    Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310900.
    >> Share

  115. SHINOMOTO M, Takeuchi C, Tatebe H, Kitani-Morii F, et al
    Comparison between DSQIID total / sub-item scores and plasma p-tau elevation in adults with Down's syndrome.
    PLoS One. 2024;19:e0311878.
    >> Share

  116. LEE GB, Jeong YJ, Kang DY, Yun HJ, et al
    Multimodal feature fusion-based graph convolutional networks for Alzheimer's disease stage classification using F-18 florbetaben brain PET images and clinical indicators.
    PLoS One. 2024;19:e0315809.
    >> Share

  117. GOLROKHIAN-SANI AA, Morcos M, Philippi A, Al-Rawi R, et al
    Temporal trends in mental health terminology in Alzheimer's disease clinical trials.
    PLoS One. 2024;19:e0310264.
    >> Share

    January 2023
  118. TIAN Y, Kuruvilla MV, Park M
    The use of virtual reality in screening for preclinical Alzheimer's disease: A scoping review protocol.
    PLoS One. 2023;18:e0282436.
    >> Share

  119. GARCIA MANRIQUEZ BA, Papapanagiotou JA, Strysick CA, Green EH, et al
    Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    PLoS One. 2023;18:e0275137.
    >> Share

  120. KARAMACOSKA D, Chan DKY, Leung I, Liu JX, et al
    Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
    PLoS One. 2023;18:e0265285.
    >> Share

  121. SHOBEIRI P, Alilou S, Jaberinezhad M, Zare F, et al
    Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281784.
    >> Share

  122. LI Y, Liu H, Li R
    Study of Bayesian variable selection method on mixed linear regression models.
    PLoS One. 2023;18:e0283100.
    >> Share

  123. LEE LH, Wu SC, Ho CF, Liang WL, et al
    White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
    PLoS One. 2023;18:e0283790.
    >> Share

  124. MRAZ H, Tong CY, Liu KPY
    Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial.
    PLoS One. 2023;18:e0283449.
    >> Share

  125. AMORIM IS, Challal S, Cistarelli L, Dorval T, et al
    A seeding-based neuronal model of tau aggregation for use in drug discovery.
    PLoS One. 2023;18:e0283941.
    >> Share

  126. FAISAL M, Aid J, Nodirov B, Lee B, et al
    Preclinical trials in Alzheimer's disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice.
    PLoS One. 2023;18:e0281003.
    >> Share

  127. BAKER E, Leonenko G, Schmidt KM, Hill M, et al
    What does heritability of Alzheimer's disease represent?
    PLoS One. 2023;18:e0281440.
    >> Share

  128. GIRGIN M, Isik S, Kantarci-Carsibasi N
    Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2023;18:e0284994.
    >> Share

  129. BAUZA M, Krstulovic M, Krupic J
    Unsupervised, frequent and remote: A novel platform for personalised digital phenotyping of long-term memory in humans.
    PLoS One. 2023;18:e0284220.
    >> Share

  130. ALATRANY AS, Khan W, Hussain A, Al-Jumeily D, et al
    Wide and deep learning based approaches for classification of Alzheimer's disease using genome-wide association studies.
    PLoS One. 2023;18:e0283712.
    >> Share

  131. SHEPHERD-BANIGAN M, Miller KEM, Hastings SN, Schleiden LJ, et al
    Use of high cost care among Veterans with comorbid mental illness and Alzheimer's Disease and related dementias.
    PLoS One. 2023;18:e0282071.
    >> Share

  132. MURPHY C, Dyer AH, Lawlor B, Kennelly SP, et al
    What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
    PLoS One. 2023;18:e0285529.
    >> Share

  133. GATTO RG, Carlos AF, Reichard RR, Lowe VJ, et al
    Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients.
    PLoS One. 2023;18:e0284182.
    >> Share

  134. FARINA MP, Saenz J, Crimmins EM
    Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires?
    PLoS One. 2023;18:e0285220.
    >> Share

  135. TAULE T, Eide IS, Fjaer L, Myrberget MA, et al
    Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.
    PLoS One. 2023;18:e0285307.
    >> Share

  136. JEMIMAH S, Chabib CMM, Hadjileontiadis L, AlShehhi A, et al
    Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0285346.
    >> Share

  137. SU Y, Wang D, Liu N, Yang J, et al
    Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer's disease mice via suppressing TLR4 signaling pathway through the gut-brain axis.
    PLoS One. 2023;18:e0286086.
    >> Share

  138. BRAUN DJ, Frazier HN, Davis VA, Coleman MJ, et al
    Early chronic suppression of microglial p38alpha in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    PLoS One. 2023;18:e0286495.
    >> Share

  139. RADWAN AA, Alanazi FK, Raish M
    Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-beta aggregation: Molecular modeling and in vitro evaluation.
    PLoS One. 2023;18:e0286195.
    >> Share

  140. JEONG WC, Min JY, Kang TG, Bae H, et al
    Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy.
    PLoS One. 2023;18:e0286727.
    >> Share

  141. TSIANOU CC, Kvetina J, Radochova V, Kohoutova D, et al
    The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.
    PLoS One. 2023;18:e0286386.
    >> Share

  142. HANTKE NC, Kaye J, Mattek N, Wu CY, et al
    Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology.
    PLoS One. 2023;18:e0286812.
    >> Share

  143. WU S, Stogios N, Hahn M, Navagnanavel J, et al
    Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286887.
    >> Share

  144. MUURLING M, Pasmooij AMG, Koychev I, Roik D, et al
    Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
    PLoS One. 2023;18:e0285807.
    >> Share

  145. KHAYER N, Motamed N, Marashi SA, Goshadrou F, et al
    RT-DOb, a switch gene for the gene pair Csf1r, Milr1, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.
    PLoS One. 2023;18:e0288134.
    >> Share

  146. MEKLI K, Lophatananon A, Maharani A, Nazroo JY, et al
    Association between an inflammatory biomarker score and future dementia diagnosis in the population-based UK Biobank cohort of 500,000 people.
    PLoS One. 2023;18:e0288045.
    >> Share

  147. THAMMASART S, Namchaiw P, Pasuwat K, Tonsomboon K, et al
    Attenuation Abeta1-42-induced neurotoxicity in neuronal cell by 660nm and 810nm LED light irradiation.
    PLoS One. 2023;18:e0283976.
    >> Share

  148. WILLIAMS E, Theys C, McAuliffe M
    Lexical-semantic properties of verbs and nouns used in conversation by people with Alzheimer's disease.
    PLoS One. 2023;18:e0288556.
    >> Share

  149. SUN Z, Zhang Y, Zhang M, Zhou S, et al
    Integrated brain and plasma dual-channel metabolomics to explore the treatment effects of Alpinia oxyphyllaFructus on Alzheimer's disease.
    PLoS One. 2023;18:e0285401.
    >> Share

  150. NI P, Pan K, Zhao B
    Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
    PLoS One. 2023;18:e0289068.
    >> Share

  151. LU H, Li J, Yang NS, Lam LCW, et al
    Using gamma-band transcranial alternating current stimulation (tACS) to improve sleep quality and cognition in patients with mild neurocognitive disorders due to Alzheimer's disease: A study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0289591.
    >> Share

  152. MONIN JK, McAvay G, Zang E, Vander Wyk B, et al
    Associations between dementia staging, neuropsychiatric behavioral symptoms, and divorce or separation in late life: A case control study.
    PLoS One. 2023;18:e0289311.
    >> Share

  153. YOON JA, Kong IJ, Choi I, Cha J, et al
    Correlation between cerebral hemodynamic functional near-infrared spectroscopy and positron emission tomography for assessing mild cognitive impairment and Alzheimer's disease: An exploratory study.
    PLoS One. 2023;18:e0285013.
    >> Share

  154. BASTOS M, da Silva MP, da Silva D, Negrao GN, et al
    Factors associated with Alzheimer's disease prevalence and mortality in Brazil-An ecological study.
    PLoS One. 2023;18:e0283936.
    >> Share

  155. ROVANG MS, Selnes P, MacIntosh BJ, Rasmus Groote I, et al
    Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database.
    PLoS One. 2023;18:e0285683.
    >> Share

  156. YAGHMAEI E, Pierce A, Lu H, Patel YM, et al
    A causal inference study: The impact of the combined administration of Donepezil and Memantine on decreasing hospital and emergency department visits of Alzheimer's disease patients.
    PLoS One. 2023;18:e0291362.
    >> Share

  157. STOLZENBURG LR, Esmaeeli S, Kulkarni AS, Murphy E, et al
    Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model.
    PLoS One. 2023;18:e0291029.
    >> Share

  158. NGUYEN TTT, Lee HH, Huang LK, Hu CJ, et al
    Heterogeneity of Alzheimer's disease identified by neuropsychological test profiling.
    PLoS One. 2023;18:e0292527.
    >> Share

  159. ZHANG GH, Chin KL, Yan SY, Pare R, et al
    Antioxioxidant and antiapoptotic effects of Thymosin beta4 in Abeta-induced SH-SY5Y cells via the 5-HTR1A/ERK axis.
    PLoS One. 2023;18:e0287817.
    >> Share

  160. HENRY DS, Pellegrino RG
    A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.
    PLoS One. 2023;18:e0292863.
    >> Share

  161. ZHOU Q, Yang D, Xiong C, Li X, et al
    Atopic dermatitis and cognitive dysfunction in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0292987.
    >> Share

  162. BOYANOVA ST, Lloyd-Morris E, Corpe C, Rahman KM, et al
    Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.
    PLoS One. 2023;18:e0286278.
    >> Share

  163. KOYCHEV I, Marinov E, Young S, Lazarova S, et al
    Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.
    PLoS One. 2023;18:e0288039.
    >> Share

  164. ISMAIL H, Khalid D, Waseem D, Ijaz MU, et al
    Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    PLoS One. 2023;18:e0286349.
    >> Share

  165. BESSER LM, Chrisphonte S, Kleiman MJ, O'Shea D, et al
    The Healthy Brain Initiative (HBI): A prospective cohort study protocol.
    PLoS One. 2023;18:e0293634.
    >> Share

  166. LI F, Chen H, Mao N, Liu H, et al
    Dietary fiber intake and cognitive impairment in older patients with chronic kidney disease in the United States: A cross-sectional study.
    PLoS One. 2023;18:e0291690.
    >> Share

  167. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    >> Share

  168. PURRO SA, Farmer M, Noble E, Sarell CJ, et al
    Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Abeta oligomer profiles unaltered by ablation of cellular prion protein.
    PLoS One. 2023;18:e0294465.
    >> Share

  169. JAHAN S, Abu Taher K, Kaiser MS, Mahmud M, et al
    Explainable AI-based Alzheimer's prediction and management using multimodal data.
    PLoS One. 2023;18:e0294253.
    >> Share

  170. ZOU T, Zhou X, Wang Q, Zhao Y, et al
    Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    PLoS One. 2023;18:e0295320.
    >> Share

  171. WU X, Cao S, Zou Y, Wu F, et al
    Traditional Chinese Medicine studies for Alzheimer's disease via network pharmacology based on entropy and random walk.
    PLoS One. 2023;18:e0294772.
    >> Share

  172. ZANG L, Liu X, Li Y, Liu J, et al
    The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer's disease: A meta-analysis.
    PLoS One. 2023;18:e0293977.
    >> Share


  173. Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases.
    PLoS One. 2023;18:e0295638.
    >> Share

  174. TANKSLEY PT, Logan MW, Barnes JC
    History of incarceration and age-related neurodegeneration: Testing models of genetic and environmental risks in a longitudinal panel study of older adults.
    PLoS One. 2023;18:e0288303.
    >> Share

  175. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    >> Share

  176. WANG E, Hagberg O, Malmstrom PU
    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
    PLoS One. 2023;18:e0292174.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016